Drawing for Q'SCORE

USPTO serial 90725086

Q'SCORE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
HELMERS, SARA A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Q'SCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MATTHEW P. WARENZAK

MATTHEW P. WARENZAK SMITH, GAMBRELL & RUSSELL, LLP1105 WEST PEACHTREE STREET, N.E.SUITE 1000ATLANTA, GA 30309

Goods and services

ClassDescriptionStatusFirst use
009Pedometers; Smartwatch bands; Smartwatches; Virtual reality glasses; Virtual reality goggles; Virtual reality headsets; Wearable computers in the nature of smartwatches; Wearable electronic proximity sensors with embedded contact tracing software for monitoring and alerting of social distances and distance measuring among wearers; Accelerometers; Apparatus for recording distance; Biometric scanners; Calorimeters; Data processing equipment; Hand scanner; Hands free devices for mobile-phones; Hands-free headsets for cell phones; Headsets for virtual reality games; Infrared sensors; Input devices for computers; LED position sensors; Motion detectors; Motion recognizing sensors; Motion sensors; Scientific apparatus, namely, spectrometers and parts and fittings therefor; Smartphones; Sports eyewear; Sports glasses; Telephones; Temperature sensors; Wearable activity trackers; Wrist-mounted smartphones; All of the foregoing excluding any diagnostic, apparatus, monitors, analyzes, or other devices for use in diagnosing or treating kidney diseaseACTIVE
010Apparatus for physical training for medical use; Blood glucose meter; Blood oxygen monitors; Blood pressure and diabetic diagnostic medical devices; Blood pressure measuring apparatus; Blood pressure monitors; Body composition analyzers for medical purposes; Body composition monitors; Body fat monitors; Cardiac event recorders; Computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; Computerized medical recording and analysis apparatus for the diagnosis and treatment of arrhythmias; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; EKG machines; Electrocardiographic (ECG) recorders; Embedded software for communicating temperature data to track illness symptoms sold as a component of thermometers for medical purposes; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Health monitors comprising sensor that monitor the health of the elderly or disabled in their own homes; Heart monitors; Heart monitors to be worn during exercise; Heart rate monitoring apparatus; Heart rate monitors; Heart rate monitors for sports activities; Heartbeat measuring apparatus; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring physiological biomarkers, namely, heart rate, blood pressure, blood oxygen saturation, blood gas concentrations, and respiratory rate; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing or treating respiratory conditions, namely, covid, flu, and sleep apnea; Medical apparatus for diagnosing suspected heart attacks; Medical apparatus for monitoring vital signs of patients; Medical apparatus in the nature of protective barriers for placement around patients for infection control purposes; Medical device, namely, a device for measuring body position during sleep; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of sensors and wireless communication modules for detecting physiological biomarkers for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, pulse oximeters; Wearable monitors used to measure biometric data for medical use; wearable wrist monitors, namely, smartwatches specially adapted to measure biometric data for medical use; Wearable devices, namely, wrist, ear, ankle, torso, and arm bands, and external and internal sensors used to measure biometric data for medical use; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; Alarms and sensors to be worn on a person while exercising for the purpose of monitoring heart rate; All of the foregoing excluding any diagnostic, apparatus, monitors, analyzes, or other devices for use in diagnosing or treating kidney diseaseACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 10, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 10, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 8, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 24, 2025TMBNTTAB RELEASE CASE TO TRADEMARKS
Feb 24, 2025OP.TOPPOSITION TERMINATED NO. 999999
Feb 24, 2025OP.DOPPOSITION DISMISSED NO. 999999
Jan 5, 2023OP.IOPPOSITION INSTITUTED NO. 999999
Oct 3, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Sep 6, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2022ALIEASSIGNED TO LIE
Jul 7, 2022DOCKASSIGNED TO EXAMINER
Jun 23, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2021DOCKASSIGNED TO EXAMINER
Aug 18, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance